ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 230 filers reported holding ICU MED INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,957,440 | -52.8% | 33,253 | -29.3% | 0.00% | -50.0% |
| Q2 2023 | $8,386,691 | +121340.6% | 47,066 | +12.4% | 0.00% | 0.0% |
| Q1 2023 | $6,906 | +2996.9% | 41,864 | +2852.3% | 0.00% | – |
| Q4 2022 | $223 | -100.0% | 1,418 | -99.0% | 0.00% | -100.0% |
| Q1 2022 | $30,213,000 | +487.1% | 135,703 | +525.9% | 0.02% | +433.3% |
| Q4 2021 | $5,146,000 | -66.6% | 21,681 | -67.1% | 0.00% | -66.7% |
| Q3 2021 | $15,394,000 | -15.8% | 65,959 | -25.8% | 0.01% | -18.2% |
| Q2 2021 | $18,283,000 | +436.0% | 88,837 | +435.1% | 0.01% | +450.0% |
| Q1 2021 | $3,411,000 | -50.3% | 16,602 | -48.1% | 0.00% | -60.0% |
| Q4 2020 | $6,857,000 | +148.4% | 31,970 | +111.7% | 0.01% | +66.7% |
| Q3 2020 | $2,760,000 | -39.0% | 15,098 | -38.5% | 0.00% | -50.0% |
| Q2 2020 | $4,524,000 | -55.6% | 24,544 | -51.3% | 0.01% | -73.9% |
| Q1 2020 | $10,178,000 | +172.0% | 50,445 | +152.2% | 0.02% | +360.0% |
| Q4 2019 | $3,742,000 | -77.8% | 20,000 | -81.1% | 0.01% | -81.5% |
| Q3 2019 | $16,860,000 | -78.7% | 105,643 | -66.4% | 0.03% | -77.3% |
| Q2 2019 | $79,132,000 | -10.5% | 314,128 | -15.0% | 0.12% | -9.8% |
| Q1 2019 | $88,465,000 | +27.5% | 369,635 | +22.3% | 0.13% | +21.1% |
| Q4 2018 | $69,385,000 | -58.7% | 302,161 | -49.2% | 0.11% | -47.1% |
| Q3 2018 | $168,134,000 | -21.2% | 594,639 | -18.1% | 0.21% | -25.9% |
| Q2 2018 | $213,234,000 | +53.9% | 726,149 | +32.3% | 0.28% | +50.3% |
| Q1 2018 | $138,509,000 | +17.0% | 548,769 | +0.1% | 0.18% | +13.5% |
| Q4 2017 | $118,388,000 | +68.6% | 548,093 | +45.1% | 0.16% | +52.3% |
| Q3 2017 | $70,210,000 | +121.8% | 377,780 | +105.9% | 0.11% | +91.1% |
| Q2 2017 | $31,657,000 | +1499.6% | 183,517 | +1316.1% | 0.06% | +1300.0% |
| Q1 2017 | $1,979,000 | -77.5% | 12,959 | -83.4% | 0.00% | -80.0% |
| Q2 2016 | $8,796,000 | -53.6% | 78,012 | -57.2% | 0.02% | -57.4% |
| Q1 2016 | $18,970,000 | +22.3% | 182,232 | +32.5% | 0.05% | +42.4% |
| Q4 2015 | $15,507,000 | -5.1% | 137,500 | -7.8% | 0.03% | +3.1% |
| Q3 2015 | $16,333,000 | +67.6% | 149,160 | +46.4% | 0.03% | +77.8% |
| Q2 2015 | $9,748,000 | -45.4% | 101,902 | -46.8% | 0.02% | -45.5% |
| Q1 2015 | $17,842,000 | -0.5% | 191,566 | -12.5% | 0.03% | -13.2% |
| Q4 2014 | $17,930,000 | +319.9% | 218,931 | +229.1% | 0.04% | +245.5% |
| Q3 2014 | $4,270,000 | +63.7% | 66,534 | +55.1% | 0.01% | +57.1% |
| Q2 2014 | $2,608,000 | +212.0% | 42,884 | +207.0% | 0.01% | +250.0% |
| Q1 2014 | $836,000 | -51.8% | 13,969 | -48.7% | 0.00% | -60.0% |
| Q4 2013 | $1,735,000 | +94.3% | 27,238 | +107.1% | 0.01% | +66.7% |
| Q3 2013 | $893,000 | – | 13,151 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |